Clinical trials: COVID19 Testing
SARS-CoV Infection
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
Minimal risk research study: 1. Comparing polyester nasal swabs and foam nasal swabs to detect SARS-CoV-2 virus; 2. Quantifying the development and trajectory of the disease through clinic visits and blood values.
- Trial name
- NCT04327804
- Testing
- Odd/Even birth year intervention groups
- Where
- United States
- Volunteers
- 139 people
- Sponsor
- UnitedHealth Group
Covid19
COVID-19 Testing in Patients With Vascular Disorders
Background: To investigate the prevalence of SARS-CoV-2 infection in hospitalized patients with vascular disorders after implementing institutional and governmental safety measures.
- Trial name
- NCT04838093
- Testing
- PCR
- Where
- Austria
- Volunteers
- 2,243 people, healthy volunteers welcome
- Sponsor
- Medical University of Vienna
COVID-19
Shaping Care Home COVID-19 Testing Policy
The goal of this interventional study is to investigate whether continued use of regular asymptomatic testing in staff is a feasible, effective and cost-effective strategy to reduce the impact of COVID-19 in care homes.
- Trial name
- VIVALDI-CT (NCT05639205)
- Testing
- Lateral Flow Device
- Volunteers
- 280 people, healthy volunteers welcome
- Sponsor
- University College, London
Long Covid
Effects of a Physical Rehabilitation Program on Long COVID
The objective of this clinical trial is to analyze the clinical, functional, and laboratory effects of a rehabilitation protocol designed for patients with long COVID; it may include any of the following: sex/gender, age groups…
- Trial name
- ReabCovid (NCT07651371)
- Testing
- Physical rehabilitation, Treadmill ergometer, Pulley
- Where
- Brazil
- Volunteers
- 74 people
- Sponsor
- Universidade do Estado do Pará
SARS-CoV-2
ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)
A randomized double-blind, placebo controlled clinical trial of the safety, tolerability, and antiviral activity of angiotensin-converting enzyme 2 (ACE2) chewing gum over a 3-day period in non-hospitalized subjects with Severe…
- Trial name
- NCT05433181
- Testing
- ACE2 Chewing Gum
- Where
- United States
- Sponsor
- University of Pennsylvania
Covid19, RSV Infection
Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test
Collection of Nasal Swabs, Throat Swabs and Saliva Samples from patients presenting at their designated care or testing facility displaying symptoms of either Influenza, Respiratory Syncytial Virus (RSV), SARS-CoV-2 or those who…
- Conditions
- Covid19, RSV Infection, Influenza Type A, Influenza Type B
- Trial name
- INFORM (NCT04782336)
- Testing
- Sample Collection
- Where
- 6 sites in United Kingdom
- Volunteers
- 79 people
- Sponsor
- LumiraDx UK Limited
Corona Virus Infection
Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era
Pre-procedure and Short-Term COVID-19 Testing of Outpatients Undergoing Non-emergent Invasive Cardiovascular Procedures
- Trial name
- RECIPE (NCT04636021)
- Testing
- COVID-19 testing
- Where
- United States
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Pinnacle Health Cardiovascular Institute
COVID-19 Pandemic
3D Printed Mask Adapter Designed From Facial 3D Scans for Fit Testing.
Healthcare workers PPE (personal protective equipment) when interacting with patients either infected or, potentially carrying SARS-CoV-2.
- Trial name
- NCT05143814
- Testing
- 3D Printed Mask Adapter Designed from Facial 3D scans for Fit testing.
- Where
- United Kingdom
- Volunteers
- healthy volunteers welcome
- Sponsor
- Barts & The London NHS Trust
COVID-19
Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
According to the WHO, contact tracing - along with robust testing, isolation, and care of cases is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing mortality associated with COVID-19.
- Trial name
- DTECT (NCT05684887)
- Testing
- Digital based contact tracing
- Where
- 22 sites in Cameroon
- Volunteers
- 433 people, healthy volunteers welcome
- Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation
COVID-19 Vaccination
A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents
The goal of this study is to refine and test CONFIDENCE, a multi-component clinic-based intervention in pediatric or family practice clinical settings.
- Trial name
- CONFIDENCE (NCT05722652)
- Testing
- CONFIDENCE
- Where
- United States
- Volunteers
- 667 people, healthy volunteers welcome
- Sponsor
- University of Massachusetts, Worcester
SARS-CoV2 Infection
Novel SARS-CoV-2 Point-of-care Testing
The aim of the project is to study the feasibility of implementing a novel point-of-care test (POCT) for rapid detection of SARS-CoV-2 infection.
- Trial name
- NCT05034978
- Testing
- no intervention
- Where
- Hong Kong
- Volunteers
- 150 people
- Sponsor
- Chinese University of Hong Kong
Covid19, Medical Emergencies
Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19
Exertional desaturation is a feature of COVID-19. The study will measure vital signs of patients discharge by practitioners in primary care, secondary care or by paramedic practitioners.
- Trial name
- NCT04618835
- Testing
- 40-Steps-test
- Where
- United Kingdom
- Volunteers
- 1,000 people
- Sponsor
- Betsi Cadwaladr University Health Board
COVID-19, Vaccine Hesitancy
Testing a Personalized Normative Feedback Intervention for Vaccine Hesitancy
Rationale: The highest rates of coronavirus disease (i.e., COVID-19) vaccine hesitancy in the US are among young adults (YAs) aged 18-25.
- Trial name
- NCT05787015
- Testing
- Vaccine Norms Feedback, Alcohol Norms Feedback
- Where
- United States
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- University of Washington
Coronavirus Disease (COVID-19)
Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations
The purpose of this study is to assess the feasibility of establishing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing at a federally-qualified health center (FQHC) during a global health crisis to mitigate…
- Trial name
- NCT04558307
- Testing
- Pilot a rapid SARS-CoV-2 testing strategy, Community-driven messages to promote COVID-19 testing
- Where
- United States
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Mayo Clinic
COVID-19
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19
This study is open to adults with COVID-19 infection who are in hospital and receive oxygen. Participants need to be 50 years of age or older and need to be at risk of further worsening of their condition.
- Trial name
- NCT04604184
- Testing
- BI 764198
- Where
- 25 sites in United States, Brazil and 4 more
- Volunteers
- 133 people
- Sponsor
- Boehringer Ingelheim
Covid19
Implementation of COVID-19 Testing Strategies in Community Health Centers
This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health…
- Trial name
- NCT04802187
- Testing
- RADx CHCs testing intervention strategy, Usual care control
- Where
- 2 sites in United States
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- Massachusetts General Hospital
Post COVID-19
Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
When the literature search is conducted, it is seen that there are many studies examining the effects of COVID-19 disease on individuals in various disease groups (MS, stroke, Parkinson, COPD, asthma, etc.) and age groups (adult…
- Trial name
- PEPICov (NCT05282043)
- Testing
- Evaluation of Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
- Where
- Turkey (Türkiye)
- Volunteers
- 68 people, healthy volunteers welcome
- Sponsor
- Istanbul Arel University
COVID-19
Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.
The Sponsor has developed a rapid screening tool intended to determine if the subject tested is COVID-19-free (Negative to COVID-19).
- Trial name
- NCT05094674
- Testing
- Breath Sample analysis
- Where
- United Kingdom
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Tera Group
SARS Virus
IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.
High-throughput screening studies identified Abl kinase inhibitors (including imatinib) as inhibitors of coronaviruses SARS and MERS. The SARS-CoV-2 coronavirus depend on Abl2 kinase activity to fuse and enter into the cells.
- Trial name
- IMAGE-19 (NCT04357613)
- Testing
- Experimental drug
- Where
- 2 sites in France
- Volunteers
- 99 people
- Sponsor
- Versailles Hospital
Covid19
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population
The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis.
- Trial name
- NCT04875520
- Testing
- Screening testing strategy, No screening testing strategy
- Where
- 5 sites in United States
- Volunteers
- 1,390 people, healthy volunteers welcome
- Sponsor
- Washington University School of Medicine